Dermatology Studies

INDICATION

AGE CRITERIA

DESCRIPTION

Atopic Dermatitis

≥ 18 yrs. old

An open-label, multi-centre drug-drug interaction trial to investigate the effects of tralokinumab on the pharmacokinetics of selected cytochrome P450 (CYP) substrates in adult subjects with moderate-to-severe atopic dermatitis –ECZTRA 4.

Chronic Pruritus

≥ 18 yrs. old

A Randomized, Double-blind, Placebocontrolled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Chronic Pruritus Of Unknown Origin.